Predictive model of increased mortality and bed occupancy if thrombolysis becomes the initial treatment strategy for STEMI during the SARS-CoV-2 pandemic

Estimated impact of altering management strategy for primary percutaneous coronary intervention (PPCI) in the UK. a) Initial management strategy for STEMI in the UK in 2018 (n=35,740). b) Predicted increase in mortality and bed day numbers with progressive increases in thrombolysis instead of PPCI for treatment of STEMI in the UK. Based on 30-day STEMI mortality in England over 3 years to 2018. Bed day calculation based on 4-day admission for PPCI-managed STEMI and 7 day for non-PPCI managed STEMI. Data from Myocardial Ischaemia National Audit Project.⁸